Sectors
OCUL
Ocular Therapeutix, Inc.
10.29
4 x 6.26
6 x 10.89
bid
ask
-
0.07
0.68%
02:10 PM
timesize
| Ytd | -15.24% | |
| 1y | -15.72% |
10.13
day range
10.40
6.23
52 week range
16.44
| Open | 10.30 | Prev Close | 10.36 | Low | 10.13 | High | 10.40 | Mkt Cap | 2.26B |
| Vol | 463.28K | Avg Vol | 2.66M | EPS | -1.40 | P/E | N/A | Forward P/E | -7.13 |
| Beta | 0.93 | Short Ratio | 13.82 | Inst. Own | 95.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 9.68 | 200-d Avg | 9.97 | 1yr Est | 27.09 |
| Income Statement | |||
| Total Revenue | 13.48M | ||
| Revenues (USD) | 13.48M | ||
| Cost of Revenue | 2.01M | ||
| Gross Profit | 11.46M | ||
| Operating Expenses | 93.57M | ||
| Research and Development Expense | 54.14M | ||
| Selling, General and Administrative Expense | 39.44M | ||
| Operating Income | -82.11M | ||
| Interest Expense | 2.79M | ||
| Net Income | -78.76M | ||
| Net Income Common Stock | -78.76M | ||
| Net Income Common Stock (USD) | -78.76M | ||
| Consolidated Income | -78.76M | ||
| Earnings per Basic Share | -0.35 | ||
| Earnings per Basic Share (USD) | -0.35 | ||
| Earnings per Diluted Share | -0.35 | ||
| Earning Before Interest & Taxes (EBIT) | -75.97M | ||
| Earning Before Interest & Taxes (USD) | -75.97M | ||
| Weighted Average Shares | 224.95M | ||
| Weighted Average Shares Diluted | 224.95M | ||
| Balance Sheet | |||
| Cash and Equivalents | 600.26M | ||
| Cash and Equivalents (USD) | 600.26M | ||
| Trade and Non-Trade Receivables | 30.26M | ||
| Current Assets | 644.43M | ||
| Property, Plant & Equipment Net | 25.28M | ||
| Total Assets | 671.32M | ||
| Debt Current | 3.12M | ||
| Total Debt | 79.38M | ||
| Current Liabilities | 49.17M | ||
| Debt Non-Current | 76.26M | ||
| Total Liabilities | 151.28M | ||
| Accumulated Retained Earnings (Deficit) | -1.32B | ||
| Shareholders Equity | 520.04M | ||
| Shareholders Equity (USD) | 520.04M | ||
| Assets Non-Current | 26.89M | ||
| Total Debt (USD) | 79.38M | ||
| Deferred Revenue | 14.00M | ||
| Inventory | 3.83M | ||
| Liabilities Non-Current | 102.10M | ||
| Trade and Non-Trade Payables | 7.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.85M | ||
| Net Cash Flow from Financing | 2.58M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -68.06M | ||
| Capital Expenditure | -3.37M | ||
| Issuance (Purchase) of Equity Shares | 2.58M | ||
| Net Cash Flow from Investing | -3.37M | ||
| Net Cash Flow from Operations | -67.27M | ||
| Share Based Compensation | 14.65M | ||